EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target

Ziyi Zhou iD, Zhaochen Feng, Xiaojia Sun, Yusheng Wang, Guorui Dou

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115516 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ziyi Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Hauptthemen laut MEDLINE: Galectin 3, Retinal Degeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Air Force Military Medical University Military Medical Enhancement Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectin-3 is the most studied member of the Galectin family, with a large range of mediation in biological activities such as cell growth, proliferation, apoptosis, differentiation, cell adhesion, and tissue repair, as well as in pathological processes such as inflammation, tissue fibrosis, and angiogenesis. As is known to all, inflammation, aberrant cell apoptosis, and neovascularization are the main pathophysiological processes in retinal degeneration and many ocular diseases. Therefore, the review aims to conclude the role of Gal3 in the retinal degeneration of various diseases as well as the occurrence and development of the diseases and discuss its molecular mechanisms according to research in systemic diseases. At the same time, we summarized the predictive role of Gal3 as a biomarker and the clinical application of its inhibitors to discuss the possibility of Gal3 as a novel target for the treatment of ocular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Galectin 3Retinal DegenerationHumansGalectinsBiomarkersInflammation

Stichwörter der Autor:innen

diagnosticsgalectin-3molecular mechanismsmolecular therapyretinal degeneration

Substanzen

Galectin 3GalectinsBiomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

ORCID-Profile: Ziyi Zhou

Förderung

  • National Natural Science Foundation of China
  • Air Force Military Medical University Military Medical Enhancement Program

Zitieren

APA

Zhou, Z., Feng, Z., Sun, X., Wang, Y., & Dou, G. (2023). The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115516

Vancouver

Zhou Z, Feng Z, Sun X, Wang Y, Dou G. The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115516

BibTeX
@article{Zhou2023,
  author = {Zhou, Ziyi and Feng, Zhaochen and Sun, Xiaojia and Wang, Yusheng and Dou, Guorui},
  title = {The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115516}
}
Kostenlos starten →